In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Mukesh Ambani's younger sons Anant Ambani and Radhika Merchant are going to get married on July 2
US President Joe Biden on Thursday passed a law establishing June 19, ie Juneteenth, as a nationa
Delhi Chief Minister Arvind Kejriwal on Wednesday said that education is necessary for every chil
Anand Mahindra congratulated the new CEO of Twitter in this way, know what he said through a tweet
Indian-origin Parag Agarwal has been appointed as the Chief Executive Officer (CEO) of micro-blog
A French reporter reporting live in Ukraine narrowly escaped a Russian missile attack. The video
The repo rate will remain at 6.5 percent, RBI Governor Shaktikanta Das announced after the MPC me
Pm Modi Speech on No Confidence Motion: The motion of no confidence brought against Prime Ministe
Yamuna Authority is going to make 10 services online from Monday. Allottees will be able to take
India captain Rohit Sharma compared the team's win in Cape Town to the win at the Gabba. Rohit ha
The country is now moving towards unlocking amidst the decreasing cases of Corona. All the monume
